CCNI expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.1017999563E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.31779999999571E-05 |
Normal-vs-Stage2 |
1.576170E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.636480E-02 |
Stage1-vs-Stage2 |
9.916300E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.966400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.868420E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.35150000027495E-07 |
Normal-vs-AfricanAmerican |
9.71640000013707E-07 |
Normal-vs-Asian |
9.1937000012976E-08 |
Caucasian-vs-AfricanAmerican |
3.338000E-01 |
Caucasian-vs-Asian |
6.127500E-02 |
AfricanAmerican-vs-Asian |
3.044000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.083620E-03 |
Normal-vs-Female |
3.7231000005189E-07 |
Male-vs-Female |
1.053010E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.941400E-03 |
Normal-vs-Extreme_Weight |
8.22140000000804E-05 |
Normal-vs-Obese |
1.266410E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.949600E-01 |
Normal_Weight-vs-Obese |
6.772800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.337000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.438400E-01 |
Normal-vs-Age(41-60Yrs) |
7.426600E-04 |
Normal-vs-Age(61-80Yrs) |
3.05550000001542E-06 |
Normal-vs-Age(81-100Yrs) |
6.632800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.177400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.993020E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.343600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.943400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.602200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.517400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.456200E-02 |
Normal-vs-Grade 3 |
6.612000E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.402800E-01 |
Grade 2-vs-Grade 4 |
7.456200E-02 |
Grade 3-vs-Grade 4 |
6.612000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.9626999999689E-06 |
Normal-vs-N1 |
2.274000E-02 |
N0-vs-N1 |
7.399600E-01 |
|
|